Cytochrome P-450 CYP2B6 Inhibitors (weak)
- Name
- Cytochrome P-450 CYP2B6 Inhibitors (weak)
- Accession Number
- DBCAT003033
- Description
Not Available
- Drugs
Drug Drug Description Crisaborole A non-steroidal topical medication used for the treatment of mild-moderate atopic dermatitis. Manidipine A dihydropyridine calcium channel blocker used to treat hypertension. Piperaquine For the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg [FDA Label]. Used in combination with DB11638. Lopinavir An HIV-1 protease inhibitor used in combination with ritonavir to treat human immunodeficiency virus (HIV) infection. Amprenavir A protease inhibitor used to treat HIV infection. Simvastatin An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular events including myocardial infarction and stroke. Clascoterone An androgen receptor antagonist used for the topical treatment of acne vulgaris in patients 12 years of age and older. Tirbanibulin A tyrosine kinase and tubulin inhibitor used to treat actinic keratosis on the face or scalp. Opicapone A catechol-O-methyltransferase inhibitor used as an adjunct treatment for Parkinson's Disease in adults currently receiving levodopa and a dopa decarboxylase inhibitor. Baloxavir marboxil A polymerase acidic endonuclease inhibitor used to treat uncomplicated influenza. Momelotinib A Janus Kinase inhibitor used to treat intermediate or high-risk myelofibrosis. - Drugs & Drug Targets